BRPI0701597A - uso de um composto antiaterotrombótico na obtenção de medicamentos destinados para o tratamento de distúrbios vasculares - Google Patents

uso de um composto antiaterotrombótico na obtenção de medicamentos destinados para o tratamento de distúrbios vasculares

Info

Publication number
BRPI0701597A
BRPI0701597A BRPI0701597-6A BRPI0701597A BRPI0701597A BR PI0701597 A BRPI0701597 A BR PI0701597A BR PI0701597 A BRPI0701597 A BR PI0701597A BR PI0701597 A BRPI0701597 A BR PI0701597A
Authority
BR
Brazil
Prior art keywords
treatment
vascular disorders
compound
antiatherothrombotic
obtain drugs
Prior art date
Application number
BRPI0701597-6A
Other languages
English (en)
Inventor
Marie-Dominique Fratacci
Agnes De Cordoue
Laurence Lerond
Tony Verbeuren
Alain Rupin
Gilbert Lavielle
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of BRPI0701597A publication Critical patent/BRPI0701597A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

USO DE UM COMPOSTO ANTIATEROTROMBóTICO NA OBTENçãO DE MEDICAMENTOS DESTINADOS PARA O TRATAMENTO DE DISTúRBIOS VASCULARES. A presente invenção refere-se ao uso de um antagonista específico de receptores de TP na obtenção de medicamentos destinados para o tratamento de distúrbios vasculares em pacientes que tiveram um acidente vascular cerebral anterior, especialmente para reduzir eventos cerebrovascular e cardiovascular em pacientes que tiveram um acidente isquêmico cerebral anterior (CIA) ou ataque isquêmico transitório (TIA).
BRPI0701597-6A 2006-04-07 2007-04-05 uso de um composto antiaterotrombótico na obtenção de medicamentos destinados para o tratamento de distúrbios vasculares BRPI0701597A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0603082A FR2899473B1 (fr) 2006-04-07 2006-04-07 Utilisation d'un compose anti-atherothrombotique pour l'obtention de medicaments destines au traitement des troubles vasculaires

Publications (1)

Publication Number Publication Date
BRPI0701597A true BRPI0701597A (pt) 2007-12-11

Family

ID=37084627

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0701597-6A BRPI0701597A (pt) 2006-04-07 2007-04-05 uso de um composto antiaterotrombótico na obtenção de medicamentos destinados para o tratamento de distúrbios vasculares

Country Status (40)

Country Link
US (1) US20070238785A1 (pt)
EP (2) EP1842537B1 (pt)
JP (1) JP2009532447A (pt)
KR (2) KR20070100658A (pt)
CN (2) CN101049292A (pt)
AP (1) AP2007003952A0 (pt)
AR (1) AR060288A1 (pt)
AT (1) ATE452633T1 (pt)
AU (1) AU2007201525A1 (pt)
BR (1) BRPI0701597A (pt)
CA (1) CA2582394A1 (pt)
CO (1) CO5820217A1 (pt)
CR (1) CR9020A (pt)
CY (1) CY1109793T1 (pt)
DE (1) DE602007003880D1 (pt)
DK (1) DK1842537T3 (pt)
EA (1) EA013874B1 (pt)
ES (1) ES2338600T3 (pt)
FR (1) FR2899473B1 (pt)
GE (1) GEP20094782B (pt)
GT (1) GT200700029A (pt)
HR (1) HRP20100091T1 (pt)
IL (1) IL182406A0 (pt)
MA (1) MA28988B1 (pt)
MX (1) MX2007004108A (pt)
NI (1) NI200700083A (pt)
NO (1) NO20071833L (pt)
NZ (1) NZ554348A (pt)
PE (1) PE20071147A1 (pt)
PL (1) PL1842537T3 (pt)
PT (1) PT1842537E (pt)
RS (1) RS51207B (pt)
SG (1) SG136882A1 (pt)
SI (1) SI1842537T1 (pt)
SV (1) SV2008003053A (pt)
TN (1) TNSN07117A1 (pt)
TW (1) TW200808306A (pt)
UY (1) UY30263A1 (pt)
WO (1) WO2007116138A1 (pt)
ZA (1) ZA200702866B (pt)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9102862D0 (en) * 1991-02-11 1991-03-27 Erba Carlo Spa N-imidazolyl derivatives of substituted or alkoxymino tetrahydronaphthalenes and chromans
RU2120292C1 (ru) * 1992-07-22 1998-10-20 Российско-германское акционерное общество закрытого типа "УТИЛЕКС" Способ лечения мозговых сосудистых кризов
FR2711139B1 (fr) * 1993-10-15 1995-12-01 Adir Nouveaux dérivés de 1,2,3,4-tétrahydronaphtalène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
DE4343776A1 (de) * 1993-12-17 1995-06-22 Schering Ag Cyclopentanonderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
JPH08119936A (ja) * 1994-10-18 1996-05-14 Fujisawa Pharmaceut Co Ltd 複素環式誘導体
FR2805261A1 (fr) * 2000-02-18 2001-08-24 Adir Nouveaux derives d'acides 6-amino ou 6-hydrazinosulfonyl-3- quinolinyl phosphoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2857593B1 (fr) * 2003-07-18 2005-10-14 Servier Lab Composition pharmaceutique orodispersible d'un compose antithrombotique
FR2860436B1 (fr) * 2003-10-03 2006-01-20 Servier Lab Nouvelle association d'un anti-atherothrombotique et d'un antiagregant plaquettaire

Also Published As

Publication number Publication date
ZA200702866B (en) 2008-07-30
NZ554348A (en) 2008-09-26
HRP20100091T1 (hr) 2010-04-30
FR2899473B1 (fr) 2008-06-13
CR9020A (es) 2008-09-23
UY30263A1 (es) 2007-05-31
ES2338600T3 (es) 2010-05-10
NO20071833L (no) 2007-10-08
AR060288A1 (es) 2008-06-04
AP2007003952A0 (en) 2007-04-30
DK1842537T3 (da) 2010-04-12
SV2008003053A (es) 2009-12-02
EA200700573A2 (ru) 2007-10-26
PT1842537E (pt) 2010-01-15
DE602007003880D1 (de) 2010-02-04
MX2007004108A (es) 2009-02-16
CO5820217A1 (es) 2007-11-30
CN101693025A (zh) 2010-04-14
GT200700029A (es) 2007-10-31
KR20070100658A (ko) 2007-10-11
MA28988B1 (fr) 2007-11-01
TW200808306A (en) 2008-02-16
GEP20094782B (en) 2009-09-25
NI200700083A (es) 2008-06-09
WO2007116138A1 (fr) 2007-10-18
SI1842537T1 (sl) 2010-03-31
TNSN07117A1 (fr) 2008-06-02
IL182406A0 (en) 2008-01-20
ATE452633T1 (de) 2010-01-15
CA2582394A1 (fr) 2007-10-07
PL1842537T3 (pl) 2010-06-30
AU2007201525A1 (en) 2007-10-25
EA013874B1 (ru) 2010-08-30
EP1842537A1 (fr) 2007-10-10
PE20071147A1 (es) 2007-12-22
SG136882A1 (en) 2007-11-29
RS51207B (sr) 2010-12-31
CN101049292A (zh) 2007-10-10
JP2009532447A (ja) 2009-09-10
US20070238785A1 (en) 2007-10-11
FR2899473A1 (fr) 2007-10-12
EP1842537B1 (fr) 2009-12-23
KR20090086500A (ko) 2009-08-13
EP2105132A1 (fr) 2009-09-30
EA200700573A3 (ru) 2007-12-28
CY1109793T1 (el) 2014-09-10

Similar Documents

Publication Publication Date Title
BRPI0921482A8 (pt) Uso de uma construção de anticorpo de cadeia simples biespecífica cd19xcd3 no tratamento de leucemia linfoblástica aguda
BRPI0518483A2 (pt) composiÇço compreendendo uma matriz ou revestimento de liberaÇço controlada e um antagonista de receptor de nmda, mÉtodo para administraÇço de tal antagonista de nmda a um paciente
BR112014010577A2 (pt) derivados de ciclo-hexilamina tendo atividade agonista beta2 adrenérgico e antagonista muscarínico m3
BR112012009376B8 (pt) composição farmacêutica sólida compreendendo um inibidor de sglt-2 e sua forma de dosagem farmacêutica
BR112014000380A2 (pt) composição farmacêutica, métodos para tratamento e usos dos mesmos
UY32000A (es) Derivados novedosos de sulfamidas sustituidas
CL2012000702A1 (es) Uso de un agonista del receptor de acetilcolina nicotinico alfa-7 para el tratamiento de la discinesia asociada a la terapia con agonista de dopamina en la enfermedad de parkinson.
BR112013027554A2 (pt) "usos de compostos no tratamento de mal de alzheimer, doença de huntington, autismo e outros distúrbios"
BR122016004010B8 (pt) forma farmacêutica oral sólida de liberação prolongada
BRPI0821027B8 (pt) 4-(4-ciano-2-tioaril)di-hidropirimidinonas para tratamento e/ou prevenção de lesões do pulmão e do sistema cardiovascular, seu processo de preparação e seu uso, e medicamento
BRPI0510224A (pt) métodos de prevenção de doença autoimunológica e artigo industrializado
CR10305A (es) "derivados sustituidos de cromanol y su uso.
BR112016012755A2 (pt) Uso de 4 a 50 mg de naltrexona de liberação sustentada, ou um sal farmaceuticamente aceitável da mesma e 50 a 400mg de bupropiona, ou um sal farmaceuticamente aceitável da mesma
CL2008000738A1 (es) Compuestos derivados de malonamida; proceso para la preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de la depresion, enfermedad de parkinson y alzheimer, entre otras enfermeda
BRPI0908541B8 (pt) uso de panax quinquefolius ou uma fração do mesmo na ativação de respostas imunes inatas e adaptativas
BR102013003570A8 (pt) Composições de plasma rico em plaquetas
CR20120549A (es) Composiciones farmacèuticas que comprenden hidromorfona y naloxona
MA32602B1 (fr) Utilisation de dronedarone pour la preparation d'un medicament pour la prevention d'un accident vasculaire cerebral ou un accident ischemique transitoire
ECSP11011101A (es) Compuestos cicloundecadepsipéptidos y el uso de dichos compuestos como un medicamento
CL2008002414A1 (es) Compuestos derivados de tetrahidronaftalenos sustituidos, composicion farmaceutica que comprende dichos compuestos, proceso de preparacion de dicha composicion y uso de los compuestos para tratar y/o prevenir trastornos del metabolismo de acidos grasos y trastornos de la utilizacion de la glucosa.
BR112013008362A2 (pt) combinações
DOP2006000280A (es) Nuevos derivados de furopirimidina acíclicos sustituidos y su uso
BRPI0516663A (pt) bengamidas que possuem um ciclocaprolactama substituìdo, processo de preparo, composições que os contém e a utilização
BRPI0511305A (pt) método de aliviar um granuloma anular ou sarcóide, artigo manufaturado e uso de um antagonista de lfa-1
UA98938C2 (ru) Лечение психологических состояний с применением антагонистов мускариновых рецепторов м1

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A E 5A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2161 DE 05/06/2012.